The initial results of using brolucizumab (Beovu®), an angiogenesis inhibitor, for choroidal neovascularization in patients with age-related macular degeneration
<p> N.S. Zhayvoronok<sup>1</sup>, O.V. Kolenko<sup>1–3</sup>, L.P. Danilova<sup>1,2</sup>, E.L. Sorokin<sup>1,3</sup> </p> <p> <sup>1</sup>Khabarovsk Branch of the S. Fedorov Eye Microsurgery Federal State Institution,...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Prime-Media
2022-11-01
|
| Series: | РМЖ "Клиническая офтальмология" |
| Online Access: | http://clinopht.com/upload/iblock/f21/xd2x9ju80w2tewy81qhgu2f30tsetl18.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|